Related Experiment Video
Updated: Jul 28, 2026
Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
Coordinated surgical and drug treatment of cancer
Abstract:
Normal cells can proliferate to heal wounds while cancer cells die from chemotherapy with selected sulfhydryl (SH) inhibitors. Choice of the drugs is directed by sensitivity tests run immediately after surgery on each patient's own cancer. The SH-bearing nonhistone chromosomal proteins were predicted to play a major role in regulating genes. Much recent work now suggests that these proteins may play a key role in controlling gene expression.
Insights
Cancer cells undergo cell death when treated with sulfhydryl (SH) inhibitors, unlike normal cells. Drug selection for chemotherapy is guided by immediate post-surgery sensitivity tests on patient tumors.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Normal cells repair wounds via proliferation.
- Cancer cells exhibit sensitivity to specific sulfhydryl (SH) inhibitors.
- Sulfhydryl (SH)-bearing nonhistone chromosomal proteins are implicated in gene regulation.
Purpose of the Study:
- To investigate the role of SH-bearing proteins in gene expression.
- To understand the mechanism of chemotherapy sensitivity in cancer cells.
Main Methods:
- Utilizing patient-derived cancer samples.
- Performing drug sensitivity tests post-surgery.
- Analyzing the function of SH-bearing proteins.
Main Results:
- Chemotherapy with selected SH inhibitors effectively induces cancer cell death.
- Sensitivity tests guide the selection of effective anti-cancer drugs.
- Emerging evidence highlights the critical role of SH-bearing proteins in gene expression control.
Conclusions:
- SH inhibitors represent a potential therapeutic strategy for cancer.
- Personalized drug selection based on sensitivity testing improves treatment efficacy.
- SH-bearing proteins are key regulators of gene expression in cancer.
More Related Videos
08:57Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice
Published on: October 5, 2017
15:04Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
Published on: January 19, 2019
Related Concept Videos
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:57Targeted Cancer Therapies
There are several types of targeted therapies against specific...
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:57Targeted Cancer Therapies
There are several types of targeted therapies against specific...
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...